CTX-2026 Antibody
CTX-2026 is a fully human monoclonal antibody directed against CD277 (Butyrophilin 3A1) . It has demonstrated anti-tumor efficacy in preclinical ovarian cancer models, making it a valuable tool for immunological and oncology research in both in vitro and in vivo experimental settings.
Product Specifications
Target
Others
Conjugation
Unconjugated
Concentration
5.77 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
47.39 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog